📖
In vivo efficacy of cefiderocol against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa carrying the AmpC E219K substitution.
Rodríguez-Coello A, Outeda-García M, García-Pose A, Gonzalez-Pinto L, Báez-Barroso GA, Guijarro-Sánchez P, Muras A, Taltavull B, Fraile-Ribot P, Alonso-Garcia I, Oliver A, Vázquez-Ucha JC, Arca-Suárez J, Bou G, Beceiro A

In vivo efficacy of cefiderocol against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa carrying the AmpC E219K substitution.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Antimicrob Agents Chemother.

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title In vivo efficacy of cefiderocol against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa carrying the AmpC E219K substitution.
Author / Organization Rodríguez-Coello A, Outeda-García M, García-Pose A, Gonzalez-Pinto L, Báez-Barroso GA, Guijarro-Sánchez P, Muras A, Taltavull B, Fraile-Ribot P, Alonso-Garcia I, Oliver A, Vázquez-Ucha JC, Arca-Suárez J, Bou G, Beceiro A
Subject & Discipline Antimicrob Agents Chemother
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-68027
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »